Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease

Neurobiology of Disease

Volumn 29, Issue 1, 2008, Pages 103-116

  Redmond Jr , D E ^a   Vinuela, A ^b   Kordower, J H ^c   Isacson, O ^b  

^a West Indies and Neural Transplantation   (United States)

^b MCLEAN HOSPITAL   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUSPENSION; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CERCOPITHECIDAE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; MALE; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; UNIFIED PARKINSON DISEASE RATING SCALE;

ANIMALS; BEHAVIOR, ANIMAL; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; EMBRYO, MAMMALIAN; FEMALE; FETAL TISSUE TRANSPLANTATION; MALE; NERVE TISSUE PROTEINS; PARKINSONIAN DISORDERS; PREGNANCY; RANDOM ALLOCATION; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 36549005041     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.08.008     Document Type: Article

References (61)

1. Barbeito L., et al. Activation of the bilateral corticostriatal glutamatergic projection by infusion of GABA into thalamic motor nuclei in the cat: an in vivo release study. Neuroscience 28 (1989) 365-374
2. Bastian A.J., et al. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Mov. Disord. 18 (2003) 1000-1007
3. Bernheimer H., et al. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological, and neurochemical correlations. J. Neurol. Sci. 20 (1973) 415-455
4. Burke R.E., et al. An assessment of the validity of densitometric measures of striatal tyrosine hydroxylase-positive fibers: relationship to apomorphine-induced rotations in 6-hydroxydopamine lesioned rats. J. Neurosci. Methods 35 (1990) 63-73
5. Cohen J. Statistical Power Analysis for the Behavioral Sciences (1988), Lawrence Erlbaum Associates, Hillsdale, New Jersey
6. Costantini L.C., et al. Medial fetal ventral mesencephalon: a preferred source for dopamine neuron grafts. NeuroReport 8 (1997) 2253-2257
7. Defer G.L., et al. Long-term outcome of unilaterally transplanted parkinsonian patients: I. Clinical approach. Brain 119 Pt 1 (1996) 41-50
8. Elsworth J.D., et al. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 95 (2000) 399-408
9. Freed C.R., et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 and 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327 (1992) 1549-1555
10. Freed C.R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344 (2001) 710-719
11. Freeman T.B., et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38 (1995) 379-388
12. Galpern W.R., et al. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Exp. Neurol. 140 (1996) 1-13
13. Gash D.M., et al. An automated movement assessment panel for upper limb motor functions in rhesus monkeys and humans. J. Neurosci. Methods 89 (1999) 111-117
14. Germano I.M., et al. Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. J. Neurosurg. 101 (2004) 36-42
15. Hagell P., et al. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122 (1999) 1121-1132
16. Hagell P., et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat. Neurosci. 5 (2002) 627-628
17. Haque N.S., et al. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Cell Transplant 6 (1997) 239-248
18. Isacson O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol. 2 (2003) 417-424
19. Isacson O., and Deacon T.W. Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience 75 (1996) 827-837
20. Isacson O., and Deacon T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 20 (1997) 477-482
21. Isacson O., et al. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1 (1995) 1189-1194
22. Isacson O., et al. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann. Neurol. 53 Suppl 3 (2003) S135-S146 discussion S146-8
23. Jenkins B.G., et al. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J. Neurosci. 24 (2004) 9553-9560
24. Kish S.J., et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N. Engl. J. Med. 318 (1988) 876-880
25. Kordower J., et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370 (1996) 203-230
26. Kordower J.H., et al. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery. Exp. Neurol. 144 (1997) 41-46
27. Leenders K.L., et al. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch. Neurol. 47 (1990) 1290-1298
28. Levivier M., et al. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact. Funct. Neurosurg. 69 (1997) 99-111
29. Lindsay R.M., and Raisman G. An autoradiographic study of neuronal development, vascularization and glial cell migration from hippocampal transplants labelled in intermediate explant culture. Neuroscience 12 (1984) 513-530
30. Lindvall O., et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247 (1990) 574-577
31. Lindvall O., et al. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31 (1992) 155-165
32. Lindvall O., et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35 (1994) 172-180
33. Lopez-Lozano J., et al. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. J. Neurosurg. 86 (1997) 931-942
34. Lopez-Lozano J.J., et al. Regression of parkinsonian fetal ventral mesencephalon grafts upon withdrawal of cyclosporine A immunosuppression. The CPH Neural Transplantation Group. Transplant. Proc. 29 (1997) 977-980
35. Ma Y., et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol. 52 (2002) 628-634
36. Mendez I., et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J. Neurosurg. 96 (2002) 589-596
37. Mendez I., et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128 (2005) 1498-1510
38. Molina H., et al. Neurotransplantation in Parkinson's disease: from open microsurgery to bilateral stereotactic approach: first clinical trial using microelectrode recording technique. Stereotact. Funct. Neurosurg. 62 (1994) 204-208
39. Nieoullon A., et al. Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat. Science 198 (1977) 416-418
40. Nyberg P., et al. Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's disease. Neurochem. Pathol. 1 (1983) 193-202
41. Olanow C.W., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54 (2003) 403-414
42. Peschanski M., et al. Bilateral motor improvement and alteration of l-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117 Pt 3 (1994) 487-499
43. Piccini P., et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci. 2 (1999) 1137-1140
44. Piccini P., et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann. Neurol. 48 (2000) 689-695
45. Przedborski S., et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J. Neurochem. 76 (2001) 1265-1274
46. Schultz W., and Romo R. Role of primate basal ganglia and frontal cortex in the internal generation of movements. I. Preparatory activity in the anterior striatum. Exp. Brain Res. 91 (1992) 363-384
47. Sladek Jr. J.R., et al. Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in nonhuman primates. Exp. Neurol. 122 (1993) 16-27
48. Slevin J.T., et al. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 102 (2005) 216-222
49. Slevin J.T., et al. Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. J. Neurosurg. 106 (2007) 614-620
50. Slowinski J.L., et al. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. J. Neurosurg. 106 (2007) 626-632
51. Spencer D.D., et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327 (1992) 1541-1548
52. Tarantal A.F., and Hendrickx A.G. Characterization of prenatal growth and development in the crab-eating macaque (Macaca fascicularis) by ultrasound. Anat. Rec. 222 (1988) 177-184
53. Tarantal A.F., and Hendrickx A.G. Use of ultrasound for early pregnancy detection in the rhesus and cynomolgus macaque (Macaca mulatta and Macaca fascicularis). J. Med. Primatol. 17 (1988) 105-112
54. Taylor J.R., et al. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Exp. Brain Res. 85 (1991) 335-348
55. Taylor J.R., Elsworth E.J., Roth R.H., Sladek Jr. J., and Redmond Jr. D.E. Behavioral effects of MPTP administration in the St. Kitts monkey: a primate model of Parkinson's disease. Toxin-Induced Models of Neurological Disorders (1994), Plenum Press, New York 139-174
56. Taylor J.R., et al. Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys. Cell Transplant 4 (1995) 13-26
57. Taylor J.R., et al. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience 81 (1997) 745-755
58. Thompson L., et al. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25 (2005) 6467-6477
59. West M.J., et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 (1991) 482-497
60. Widner H. Review of allo- and xenogeneic neural grafts in neurodegenerative disorders. Neural Tissue Transplantation Team (NETTLU). Transplant. Proc. 31 (1999) 936-938
61. Youngerman B.E., Redmond Jr. D.E., Kordower J.H., and Isacson O. Levodopa induced dyskinesia in the St. Kitts (African) green monkey. Parkinsonism and Related Disorders. Abstracts of the 16th International Congress on Parkinson's Disease and Related Disorders vol. 11 (2005) 232